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Summary: Preincubation of human skin fibroblasts in the presence of 10~~6—10~5 mol/1 glucocorticoids
J j (dexamethasone) causes a concentration and time-dependent increase of receptor-mediated internalisation of
1 1 [125I]LDL. This increase is due to a glucocorticoid-specific Stimulation by 40 — 50% of LDL receptor synthesis
äs demonstrated by an increased incorporation of [35S]methionine into immune precipitated receptor protein.
In contrast the rate of synthesis of total cell protein and of lysosontäl cathepsin D is not significantly
infiuenced by dexamethasone.
^ The increased LDL receptor synthesis is accompanied by an enhanced synthesis of cholesterol from
| ; [2-3H]mevalonolactone and [l-14C]acetate. The glucocorticoid-induced enhancement of LDL receptor and
t . cholesterol synthesis is abolished by preincubation of the cells with dexamethasone in combination with
\ 25-hydroxycholesterol.
Glucocorticoid-stimulierte Biosynthese des LDL-Rezeptors in kultivierten Hautfibroblasten
Zusammenfassung: Vorinkubation menschlicher Hautfibroblasten in Gegenwart von 10~6—10~~5 mol/1 Gluco-
corticoiden (Dexamethason) führt zu einer konzentrations- und zeitabhängigen Zunahme der Rezeptor-
vermittelten Aufnähme von [125I]LDL. Diese Zunahme ist bedingt durch eine glucocorticoidspezifische
Stimulation der LDL-Rezeptorsynthese um 40 — 50% und läßt sich durch eine vermehrte Inkorporation von
[35S]Methionin in das durch Immunpräzipitation gewonnene Rezeptorprotein nachweisen. Die Syntheserate
der zellulären Gesamtproteine und des lysosomalen Cathepsin D wird dagegen durch Dexamethason nicht
signifikant beeinflußt.
Die glucocorticoid-abhängige Zunahme der LDL-Rezeptorsynthese ist begleitet von einer erhöhten Choleste-
rinsynthese aus [2-3H]Mevalpnolacton bzw. [l-14C]Acetat. Die Glucocorticoid-induzierte Zunahme der
Synthese des LDL-Rezeptors und des Cholesterins bleibt aus nach Vorinkubation der Zellen mit Dexametha-
son in Kombination mit 25-Hydroxycholesterin.
- * cellular cholesterol synthesis and an Inhibition of
Introduction
 LDL receptor synthesis (for review see I.e. (1)). A
Receptor specific binding and internalisation of hom- correlation between the extent of cholesterol synthesis
ologous low density lipoproteins by human skin and the HMG-CoA reductase1),2) activity has been
fibroblasts are known to initiate a suppression of observed in various Systems in vivo and in vitro '
(2—4) and is assumed to reflect the conversion of
l) Abbreviations. LDL, low density lipoprotein; HMG-CoA, HMG-CoA into mevalonic acid äs the rate-limiting
3-hydroxy-3-methylglutaryl-CoA; SDS, sodiüm dodecyl
 step jn \fa COUrse of cholesterogenesis. However,
·») Enzime's. Hydroxymethylglutaryl^CoA reductase (EC various ce" lines grow^ in thf. Presenf
 f
of
1.1.1.88, mevalonate: NAD+ oxidoreductase). glucocorticoids do not conform to this general rule.
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Thus, in HeLa cells the increased cholesterol synthesis
from acetate after serum removal from the medium
was partially suppressed by dexamethasone, but this
suppression was not accompanied by an expected
decrease in activity of HMG-CoA reductase (5). Also,
in a variety of cell lines grown in the presence of
dexamethasone the incorporation of acetate into
cellular cholesterol was suppressed while HMG-CoA
reductase activity was either elevated or remained
unchanged (6, 7).
The glucocorticoid effect seems to depend on the
sensitivity of the cell line and the glucocorticoid con-
centration. Thus, Brown & Goldstein (4) have shown
that growth of fibroblasts in the presence of cortisol
had no effect on HMG-CoA reductase activity even
at l O"5 mol/1 concentration while in HeLa and HTC
cells (6) glucocorticoids were effective in the induction
of HMG-CoA reductase at concentrations ranging
from 10-6 mol/1 (6) to IQ-8 mol/1 (5). Moreover, there
was a demoEßtrated parallel between the magnitude
of enzyme induction and glucocorticoid potency, so
that the order of activity was dexamethasone >
prednisolone > cortisol (5).
The criteria used in previous studies on the influence
of glucocorticoids on cholesterol metabolism were
(I) the incorporation of [14C]acetate or [3H]me-
valonolactone into cholesterol (5 — 7),
(II) the activity of HMG-CoA reductase (4-7) and
(III) bindung and intracellular processing of LDL
(8), but no Information is available on the synthesis
of the LDL receptor.
Therefore in the present studies we examined the
biosynthesis of LDL receptor under the influence of
dexamethasone and cortisol. The results are based on
measurements of LDL receptor synthesis by immu-
noprecipitation and fluorography of LDL receptor
after pulse labelling with [35S]methionine, according
to Tolleshaug et al. (9). Control experiments were
performed to determine the synthesis of total cell
protein, of cathepsin D (pulse labelled with
[35S]methionine and immune precipitated), and of
cellular cholesterol.
The presented data may be important not only in
terms of the further understanding of the mechanism
of action of glucocorticoids but could also contribute
to a more rational use of steroid analogues äs
chemotherapeutical agents. We have therefore exam-
ined not only the physiological concentrations of
glucocorticoids but also their therapeutical doses.
Materials and Methods
Materials
Steroids were pürchased from Sigma, 25-hydroxycholesterol
from Steraloids Inc. (Wilton, NH, USA), [35S]methionine from
NEN, [l-14C]acetate, D,L-[2-3H]mevalonic acid lactone and 125I
(carrier free) from the Radiodhemical Centre Amersham. All
other chemicals used were from known.-spurces and of analytical
grade. All steroids were dissolved in dimethyl sulphoxide and
added to the culture medium to give a final dimethyl sulphoxide
concentration which did not exceed 5 ml/l medium.
Methods
Lipoprotein
Human low density lipoproteins (d = 1.02—1.055 kg/l) were
isolated and labelled with 125I äs described previously (10)
yielding specific activities of 8— 12 l O4 counts/min · \ig LDL
protein. 95—97% pf the radioactivity was precipitable with
100 g/l trichloroacetic acid. Lipoprotein-deficient serum was
prepared by ultracentrifugation at d = 1.22 kg/l.
Cells
Normal human fibroblasts were gfown from the skin explant
of a normal infant and were used för ihcubation experiments
between the third and eight passäges. Incubation conditions
are described in the corresponding figures and tables.
Assays
The binding, internalisation and degradation assays of
[125I]LDL were performed at 37 °C, using the method of
Brown & Goldstein (4). Bindung and uptake of 125I-labelled
epidermal growth factor were determined according to Kita et
al. (11). Protein was determined by the method of Kaltwasser
et al, (12).
Lipid analyses
Lipids were extracted from the cell with Chloroform: methanol
(2+ 1 by volume) and separated into individual lipid classes on
silica G plates äs described previously (13). Trace amounts of
diglycerides were elimmated frönt the cholesterol fraction by
digitonin precipitation.
Antibodies against LDL receptor
The LDL receptor from bovine adrenal cortex membranes
was isolated and purified according to Schneider et al. (14).
Antibodies against the LDL receptor were produced in rabbits
according to Kita et ai. (11). Aiitibodies from goat directed
against rabbit -globulins were a gift from Dr. B. Voss, Institute
of Arteriosclerosis Research, Münster. Rabbit antibodies
directed against human placentäl cathepsin D (15) were a gift
from Dr. Gieselmann in the authors' institute.
LDL receptor synthesis
LDL receptor was labelled by a 3 hour pulse of cultured cells
with 5.6 öBq/1 of [35S]methionine in methionine-free medium.
After extensive washings the cells were lysed, LDL receptor
was precipitated from the cell lysate by specific antibodies and
analysed by SDS electrophoresis äs described (9). 35S-Labelled
cathepsin D was immune precipitated and analysed according
tol.c. (15).
The radioactivity in the receptor or cathepsin D bands was
determined following digestion of the bands in a mixture of
H2O2 and ammonia (99 + 1 by volume) for 12 hours at 55 °C.
Incorporätion of [35S]methionine into total cell proteins was
0
 determined in an aliquot of cell lysates following trichloroacetic
acid precipitation and extensive washing.
l- \
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Radioaclivity
125I-Radioactivity was counted in a γ-counter (Berthold Modell
5300). 35S-, 3H- and 14C-radioactivity were determincd by
scintillation counting.
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Fig. l Effect of dexamethasone on the binding of [I25I]LDL
to human skin fibroblasts. Cells were preincubated in
lipoprotein-free medium for 48 h with the specified con-
centrations of dexamethasone prior to adding to the
medium either 5 mg/1 [I25I]LDL or 5 mg/1 [t25I]LDL +
300 mg/1 non-labelled LDL. High affmity binding was
determined after 6 h. Means and Standard errors are
calculated from 4 experiments made in duplicate.
Figures of control experiments were set s 1.00.
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Fig. 2. Time-dependent increase of fl25I]LDL binding to human
skin fibroblasts after preincubation of the cells with 12
μηιοΐ/ΐ dexamethasone for the specified periods (con-
trol = 1.00). Means and Standard errors of 3 experi-
ments. Incubation conditions s in figure 1.
Results
Preincubation of monolayers of human skin
fibroblasts with dexamethasone causes a con-
centration-dependent increase (up to 50%) of re-
ceptor-mediated binding (fig. 1), internalization and
degradation (not shown) of LDL, compared with cell
cultures preincubated without glucocorticoids or in
the presence of oestradiol-17 (tab. 1). The effect on
LDL binding is detectable after a short lag phase and
reaches maximal values after preincubation of the
cells in the presence of effective steroids for 48 hours
(tab. l, fig. 2).
The glucocorticoid-induced increase of LDL receptor
activity was correlated with a Stimulation of LDL
receptor synthesis s indicated by a higher rate of
incorporation of [35S]methionine into receptor protein
(tab. 2). SDS gel electrophoresis of the immune pre-
cipitate according to 1. c. (8) yielded the mature LDL
receptor and its precursor form s single bands with
apparent molecular weights of about 160000 and
120000 respectively. The specificity of the antibody
was ascertained f>y the observation that addition of
5 mg/1 medium of immunoglobulin entirely prevented
LDL from binding to the cell surface receptor. The
increased labelling of the LDL receptor after pre-
incubation of the cells in the presence of 6 and 12
μηιοΐ/ΐ dexamethasone s shown in figure 3a (left
Tab.l. Effect of steroid hormones on metabolism of [125I]LDL
in human skin fibroblasts. Cells were preincubated for
48 hours with 12 μιποΐ/ΐ concentration of effectors in
lipoprotein-deficient medium prior to adding 5 mg/l of
[t2SI]LDL in the presence or absence of 300 mg/l of
nonlabelled LDL apoprotein. After 6 hours cells were
extensively washed, then trypsinised. High affinity bind-
ing, intemalisation and degradation were calculated by
subtracting the radioactivity bound, internalized and
degraded in the presence from that obtained in the
absence of nonlabelled LDL. Data are means + Stan-
dard deviation of 5 experiments.
Pre- [125I]LDL metabolism
incubation Binding Inter- Degradation
with nalization
(LDL apoprotein, ng/mg cell protein)
None
(control)
Dexa-
methasone
Cortico-
sterone
Hydro-
cortisone
Oestra-
diol-17
126 ± 15 648 ± 53 2389 ± 301
180 ± 24* 1063 ± 146* 3889 ± 519*
157 ± 18* 926 ± 89* 3043 ± 317*
162 ± 29** 894 ± 91* 2987 ± 246**
129 ± 13 627 ± 32 2334 ± 172
* significance vs. control p <0.01
** significance vs. control p <0.05
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Tab. 2. Incorporation of [35]methioninc into LDL-receptor protein, cathepsin D and total cell protein of human skin fibroblasts
s influenccd by dexamethasone. Cells were preincubated for 48 hours in lipoprotein-deficient medium in the absence or
presencc of efiectors and than pulsed for 3 hours with 5.6 GBq/1 of [35S]methionine (LDL-receptor) and for 30 min
(cathepsin D) in methionine-free medium. Afterwards the cells were lysed and radioactivity in LDL receptor, cathepsin
D and total protein was determined s described in Methode. Fraction of control values (= 1.00) in brackets. Data are
means of duplicate values.
Preincubation
conditions
Control
Dexamethasone
Dexamethasone
Concentration
(μιηοΐ/l)
6
12
LDL receptor
(counts/min · mg cell protein)
8550(1.00)
11970(1.40)
12560(1.48)
Cathepsin D
(counts/min ·
39040(1.00)
39480 (1.01)
39160 (1.00)
mg cell protein)
Cell protein
(counts/min · mg)
181600000(1.00)
176100000 (0.97)
172500000 (0.95)
panel, track A and B) was confirmed by quantitative
counting of the receptor bands (tab. 2). Cells pre-
incubated in the presence of 6 and 12 μιηοΐ/ΐ dexa-
methasone incorporated 40% and 48% more
[35S]methionine into the immune precipitated LDL-
receptor protein than cells incubated in the absence
of the effector. Preincubation of the cells with a
g
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Fig. 3. Incorporation of [35S]methionine into the LDL receptor
(a) and cathepsin D (b) of human skin fibroblasts. After
preincubation for 48 h in lipoprotein-free medium the
cells were labelled for 3 h (LDL receptor) and 30 min
(cathepsin D) with 5.6 GBq/1 [35S]methionine, then
washed and lysed. The LDL receptor and cathepsin D
were immune precipitated from cell lysates, separated
by SDS gel electrophoresis and visualized by flu-
orography. (a) Immune precipitates of LDL receptor
from cells preincubated in the presence of 12 μηαοΙ/1 (Α),
6 μηαοΐ/ΐ (B) or absence (C, control) of dexamethasone
and in the presence of a combination of 12 μιηοΐ/ΐ
dexamethasone, 20 mg/1 cholesterol, arid l mg/1 of 25-
hydroxycholesterol (D), (b) Immune precipitates of
cathepsin D from cells preincubated in the presence
of 6 μιηοΐ/ΐ (F) and 12 μηιοΐ/ΐ dexamethasone (G). E,
control.
combination of dexamethasone and 25-
hydroxycholesterol (fig. 3a, left panel, track D)
completely abolished the incorporation of
[35S]methionine into the LDL receptor protein.
In control experiments the rate of synthesis of
lysosomal cathepsin D s influenced by dexa-
methasone was determined under strictly identical
conditions. SDS gel electrophoresis pf immune pre-
cipitated cathepsin D after pulse labelling with
[35S]methionine results in the formation f a 53000
dal ton precursor, a 47000 dalton intermediate and a
31000 dalton mature form. As shown in fig re 3b
(right panel) and table 2, dexamethasone has no in-
fluence on the sum of [35S]methionine incoipqfated
into the different forms of cathepsin D.
Incorporation of [35S]methionme into the total cell
protein was not elevated under the influence of dexa-
methasone in relation to controls (tab. 2).
The glucocorticoid-enhanced LDL receptor activity
and synthesis was fo nd to be glucocorticoid-specific
but not LDL receptor-specific. Thus, after pre-
incubation of the cells with 12 μπιοΐ/ΐ dexamethasone
the receptor mediated binding and internalisation of
[125I]epidermal growth factor is augmented from the
control values (37 ± 6 ng/mg cell protein) to 64
± 7 ng/mg cell protein. The gluc corticoid-induced
increase of LDL receptor synthesis and LDL receptpr
activity is abolished by preincubation of the cells with
cycloheximide, native LDL (not shown) or with a
combination of dexamethasone and 25-hy-
droxycholesterol (fig. 3, Track C arid tab. 2).
The incorporation of [2-3H]mevalonolactone and
[l-14C]acetate into cholesterol are increased by dexa^
methasone to the same extent s the LDL receptor
activity and synthesis, these effects being prevented
likewise by a preincubation of the cells with dexa-
methasone in combination with 25-hy-
droxycholesterol (tab. 3).
r
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Tab. 3. Incorporation of [l-!4C]acetate and [2-3H]mevalonolactone into ceilular cholesterol of human skin fibroblasts. Celis were
preincubated for 48 h in lipoprotein-deficient medium in the presence or absence of the specified effectors and then
radiolabelled for a further 6 h with 3.7 GBq/1 of either [l-14C]acetate or [2-3H]mevalonolactone. The total lipids extracted
from the cells were fractionated on silica-G plates-and the cholesterol analysed for radioactivity. Data are means ±
Standard deviation of 4 experiments.
Preincubation wilh
None
Dexamethasone
Dexamethasone
H- 25-Hydroxycholesterol
Concentration
( / )
12
12 -f 2.5
Cholesterol synthesis
[l-I4C]Acetate
(counts/min · mg cell protein)
800000 ± 10000
1200000 ± 170000
< 50000
[3H]Mevalonolactone
(counts/min · mg cell protein)
96000 ± 11000
138000 ± 14000
n.d.
n. d., not determined
H
t
f-
lf
Discussion
The present studies provide evidence that treatment
of cultured human fibroblasts with synthetic or nat-
ural glucocorticoids initiales a Stimulation of LDL
receptor synthesis. This was indicated by a higher
rate of [35S]methionine incorporation into the LDL
receptor protein, which was measured after im-
munoprecipitation with specific antibodies. The en-
hanced rate of receptor synthesis is accompanied by
an increased binding and internalization of [125I]LDL,
providing evidence that an increased receptor
synthesis increases the number of cell membrane
bound functional LDL receptors. As a concomitant
effect an increase in the incorporation of
[2-3H]mevalonolactone and [l-14C]acetate into
cholesterol was observed.
In our fibroblast culture Systems glucocorticoids were
ineffective at physiolögical concentration (10~~7 mol/1).
This confinns earlier firidings that human skin
fibroblasts seem to be less sensitive towards
glucocorticoids than pther cell lines. Whereas in
HeLa (6, 7) and HTC (6) cells pretreated with 10~6
mol/1 dexamethasone the HMG^CoA reductase catä-
lytic activity increased to 175—200% of the control
values, in fibroblasts (2) the enzyme activity was not
significantly affected, even at 10"5 mol/1 dexa-
methasone. Also Henze et al. (16) observed an
unchanged binding of LDL by cultured human skin
fibroblasts pretreated with 4.1 x , 10~8 mol/1
hydrocortisone. In the present experimerit the
glucocorticoid dose reqüired for Stimulation of LDL
receptor synthesis (5 —10 10~6 mol/1) corresponds
to the serum glucocorticoid level after application of
therapeutic doses of glucocorticoids.
The mechanism by which dexamethasone stimulates
LDL receptpr synthesis is not yet clear. In HeLa cells
high affinity binding of LDL was not affected by
10~6 mol/1 dexamethasone but processing of LDL
after its internalisation was altered so that the cell-
associated LDL was reduced by dexamethasone to
20-60% of the control value (8). Also, Henze et al.
(16) observed an unchanged binding but a decreased
internalization and degradation of LDL by cultured
human skin fibroblasts pretreated with physiolögical
concentrations of hydrocortisone.
An inverse effect is observed in cultured fibroblasts
at 5 —10 10"6 mol/1 dexamethasone. The data in
table l show an enhanced binding and internalisation
of [125I]LDL äs a result of an increased LDL receptor
synthesis (fig. 3), but it appears doubtful whether this
effect reflects a physiolögical action of
glucocorticoids. The fact that the dexamethasone-
induced increase of LDL receptor synthesis could
be suppressed when the cells were incubated with a
combination of dexamethasone and 25-hy-
droxycholesterol suggests that dexamethasone in
higher concentrations prevents the intracellular form-
ation of oxygenated cholesterol derivatives which are
known to be powerful inhibitors of cholesterol bio-
synthesis in various types of cells in culture and in
vivo (17). Such oxygenated sterols, for example 24,25-
oxidolanosterol (18) are generated from squalene
2,3:22:23-dioxide, which can be metabolized into
compounds more polar than cholesterol. Squalene
2,3:22:23-dixoide is not a normal intermediate of cho-
lesterol biosynthesis, but is formed from squalene
2,3-epoxide (an obligatory precursor of cholesterol)
when the enzyme squalene 2,3-epoxide cyclase is par-
tially inhibited (19). A complete Inhibition of
squalene 2,3 epoxide cyclase, however, would prevent
the formatiön of oxygenated sterols and hence lessen
the inhibition of HMG-CoA reductase, with the re-
sült that cholesterol and LDL receptor synthesis are
stimulated.
The glucocorticoid-induced increase of LDL receptor
synthesis was shown to exhibit relative specificity.
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Thus, on the one band the rate of synthesis of a
lysosomal marker enzyme, cathepsin D, was not in-
fluenced and the synthesis of total cell protein was
not elevated by dexamethasone. On the other hand
not only the endocytosis uptake of LDL but also
the receptor-mediated endocytosis of the epidermal
growth factor was enhanced by dexamethasone. This
is in accordance with findings of Sadig et al. (15),
who observed a betamethasone-induced increase of
foetal pulmonary epidermal growth factor. Froin
these results it is concluded that glucocorticoids in the
concentrations used effect a selective augmentation in
the synthesis of glucocorticoid dependent proteins,
but do not exert a general stimulating effect on pro-
tein biosynthesis. The elevated incorporation of
[2-3H]mevalonolactone and [14C]acetate into cho-
lesterol süggests that pace maker enzymes of cho-
lesterol synthesis are regülated by glucocorticoids.
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